BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220421
DTEND;VALUE=DATE:20220701
DTSTAMP:20260516T020253
CREATED:20220425T094247Z
LAST-MODIFIED:20220519T120013Z
UID:33903-1650499200-1656633599@www.pharmajournalist.com
SUMMARY:CPhI & P-MEC China Virtual Expo Connect
DESCRIPTION:This year CPhI & P-MEC China returns as a SMART event\, combining 2 months of online event with a 3-day in-person event to help you connect for an extended period. \n \n“Virtual Expo Connect”\, to be held from 21st April – 30th June 2022\, is the digital extension of the physical CPhI & P-MEC China event that offers an online alternative for global pharma professionals. \nPowered by PharmaSources.com\, Virtual Expo Connect builds the online platform adding valued services and infinite opportunities to connect\, learn\, trade and grow. \nTo know more visit: https://www.pharmasources.com/vec2022
URL:https://www.pharmajournalist.com/event/cphi-p-mec-china-virtual-expo-connect-2/
LOCATION:Online
ORGANIZER;CN="Informa Markets":MAILTO:Yingqi.shi@imsinoexpo.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220509
DTEND;VALUE=DATE:20220511
DTSTAMP:20260516T020253
CREATED:20220124T115213Z
LAST-MODIFIED:20220124T115300Z
UID:32925-1652054400-1652227199@www.pharmajournalist.com
SUMMARY:SMi’s 6th Annual Highly Potent Active Pharmaceutical Ingredients
DESCRIPTION:SMi’s 6th Annual Highly Potent Active Pharmaceutical Ingredients \nConference: 9 – 10 May 2022\nLondon\, UK\nWebsite: www.highlypotentapi.com/WLPJ \nChaired by Justin Mason-Home\, Owner\, Director\, HPAPI Project Services Limited  \nEnsuring Risk-Based\, Safety-Driven\, High-Quality Operation \nSMi is proud to present its 6th Annual Highly Potent Active Pharmaceutical Ingredients\, taking place on the 9 – 10 May 2022. \nThe Global High Potency API/HPAPI Market is projected to reach 37 billion USD by 2027\, growing at an ever-increasing CAGR of 8.43%. The expanding production of high potency APIs\, along with the increase in associated toxicities\, are driving requirements for more effective containment solutions and much-needed guidelines to ensure worker safety. \nSMi Group are delighted to announce the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference will be taking place on 9th – 10th May 2022 in London\, UK. The conference will encompass the critical topics including risk assessment\, occupational toxicology\, engineering controls for containment\, facility design\, and the impact of pharmaceutical manufacture on the environment. \nBenefits of Attending the HPAPI Conference: \n\nDissect comprehensive hazard assessment and occupational exposure limit determination\nEvaluate the increasing trend toward more potent therapies and the consequences of the changing face of pharma\nAssess engineering containment controls\, from isolators and barriers to fully automated lines\nExplore the employment of cleaning validation\, organisational controls\, and facility as key measure to tackle cross contamination\n\nThis two-day conference offers you peer-to-peer networking with industry experts including heads and directors of EHS\, Occupational Hygiene\, Quality Assurance and more. Expand your community and explore the latest developments in the industry at this two-day event\, including key regulatory updates\, and leading case studies from leading pharmaceutical and biotechnology companies. \nEarly Birds: \n\nRegister by 31st January to save £400\nRegister by 28th February to save £200\nRegister by 31st March to save £100\n\nEvent Hashtag: #SMiHPAPi
URL:https://www.pharmajournalist.com/event/smis-6th-annual-highly-potent-active-pharmaceutical-ingredients/
LOCATION:Copthorne Tara Hotel\, Scarsdale Place\, Kensington\, London\, W8 5SY\, United Kingdom
ORGANIZER;CN="SMi Events":MAILTO:ngaloria@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220509
DTEND;VALUE=DATE:20220512
DTSTAMP:20260516T020253
CREATED:20220222T100531Z
LAST-MODIFIED:20220222T100531Z
UID:33327-1652054400-1652313599@www.pharmajournalist.com
SUMMARY:LEAP HR: Life Sciences West 2022
DESCRIPTION:LEAP HR: Life Sciences West is your best opportunity to hear how scaling life sciences organizations are implementing the experimental people strategies required to drive innovation and growth whilst operating in a tight talent market. \nStep inside 30+ case studies of the radical\, future-focused HR thinking that will empower you to transform your impact and turbocharge scale and innovation in biotech\, pharma and medical devices organizations. \nGain access to the HR innovation that is truly making a difference to employees\, patients and customers – and leave with a brand-new playbook for the people function to thrive in the fast-paced operating environments of life sciences organizations on the West Coast and surrounding areas. \nWith a world-class speaker faculty from leading life sciences organizations such as: Atara Biotherapeutics\, Gilead Sciences\, BridgeBio\, Assembly Biosciences\, Revolution Medicines\, 10X Genomics and many more. \nWhether your business is rapidly growing\, undergoing serious transition or quickly evolving\, LEAP HR: Life Sciences West is your opportunity to plug into a ready-made network of peers who have already solved the talent challenges you’re facing in a candidate-led talent market on the tech-hub West Coast and surrounding areas. \nTo know more visit: https://bit.ly/3h3w3Nt
URL:https://www.pharmajournalist.com/event/leap-hr-life-sciences-west-2022/
LOCATION:Marriott La Jolla\, 4240 La Jolla Village Dr\, La Jolla\, CA\, 92037\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220510
DTEND;VALUE=DATE:20220513
DTSTAMP:20260516T020253
CREATED:20220105T163123Z
LAST-MODIFIED:20220106T100246Z
UID:32667-1652140800-1652399999@www.pharmajournalist.com
SUMMARY:Adenosine-Pathway Targeted Cancer Immunotherapy Summit
DESCRIPTION:Adenosine-pathway therapies have produced a plethora of promising clinical trial data that is being met with refreshed excitement\, enthusiasm\, and R&D investment for adenosine-pathway targets. \nWith reinvigorated confidence in the field\, join fellow industry and academic thought leaders at the inaugural Adenosine-Pathway Targeted Cancer Immunotherapy Summit. This is the only comprehensive forum dedicated to optimizing efficacy of adenosine-pathway targeted drugs\, overcoming challenges of resistance and immunosuppression and supercharging therapeutics to patients in need. \nFrom analyzing the latest developments in understanding adenosine signaling in the TME\, to rationalizing drug combinations that enhance patient responses\, and exploring tools that quantify adenosine to select patients\, this is the one-stop-shop event for all things adenosine-pathway. \nHarness cutting-edge insights across 3 days of exclusive content from industry heavyweights including Astrazeneca\, Takeda\, Corvus Pharmaceuticals\, iTeos Pharmaceuticals\, Domain Therapeutics and more. Leave this definitive conference equipped with novel ideas\, actionable lessons learned and new connections enabling you to progress your adenosine-pathway targeted cancer immunotherapies to the clinic. \nTo know more visit: https://ter.li/q8tgbz
URL:https://www.pharmajournalist.com/event/adenosine-pathway-targeted-cancer-immunotherapy-summit/
LOCATION:Omni Parker House\, 60 School St\, Boston\, MA\, 02108\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220510
DTEND;VALUE=DATE:20220513
DTSTAMP:20260516T020253
CREATED:20220207T093750Z
LAST-MODIFIED:20220207T093750Z
UID:33162-1652140800-1652399999@www.pharmajournalist.com
SUMMARY:7th Annual 3D Tissue Models Summit 2022
DESCRIPTION:Integrate Advanced 3D Models with Scalability & Predictability to Supercharge Your Modeling Toolbox & Enhance Clinical Confidence \nFollowing the FDA’s announcement of ‘Alternative Methods Working Group’ in the summer\, 2021\, Roche’s newly opened pRED Innovation Center in Basel\, and exciting data from Recce Pharma’s anti-infective candidate using organoids\, the 7th Annual 3D Tissue Models Summit will return to Boston in May 2022 to reunite the community of drug discovery and development experts. This is the definitive meeting for drug developers to explore and integrate complex 3D models featuring 30+ real-life case studies across 2 dedicated tracks and their lessons learned. \nJoin us in May to stay ahead of the curve and through 30+ real-life case studies\, you will learn and meet trailblazers in 3D models to revolutionize your drug discovery and development protocols\, giving you greater confidence in clinical relevancy and accelerating novel treatments to patients in a safe and affordable manner! \nTo know more visit: https://ter.li/oly672
URL:https://www.pharmajournalist.com/event/7th-annual-3d-tissue-models-summit-2022/
LOCATION:Hilton Boston Back Bay\, 40 Dalton St\, Boston\, MA\, 02115\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220510
DTEND;VALUE=DATE:20220513
DTSTAMP:20260516T020253
CREATED:20220216T112754Z
LAST-MODIFIED:20220216T112754Z
UID:33261-1652140800-1652399999@www.pharmajournalist.com
SUMMARY:3rd Manufacturing Engineering & Facility Management in Pharma Summit
DESCRIPTION:Following innovative technological breakthroughs and the FDA’s Emerging Technology Program\, the pharmaceutical industry is experiencing a renaissance period with an unprecedented level of investments in new builds and next-generation technology to support novel pipeline progression. \nThe ability to commission a modern\, flexible\, compliant facility on time and a budget have never been so critical to drug developers and patients worldwide. \nThe 3rd Manufacturing Engineering & Facility Management in Pharma Summit is the industry’s first definitive discussion and networking forum designed to reunite leaders in the manufacturing and facilities fields in person after two years to share scientific breakthroughs and address challenges the industry is facing. With the pharmaceutical industry entering Pharma 4.0\, technology advances and facilities designs must adapt to a digital\, remote world to enhance tomorrow’s CGT pipeline. \nDesigned alongside the likes of Bayer\, AstraZeneca\, and Catalent\, this industry-focused forum allows you to discuss novel cutting-edge technologies\, the latest approaches of engineering modular\, flexible facilities and address the supply chain crisis. \nWith 22+ hours of content\, 3 interactive workshops\, and over 2 hours of networking with key industry leaders\, this comprehensive forum will uniquely combine leaders in the manufacturing\, engineering\, and facilities fields in one setting to share lessons learned\, case studies\, and advancements in the field. \nJoin 80+ of your peers and be part of this unique opportunity to engage in cross-industry discussions and presentations from 20+ expert speakers on sharing technology innovations that are transforming the manufacturing field\, maximizing productivity and capital efficiency through excellent engineering and facility management\, and collaborating with stakeholders to ensure on-time\, on-budget commissioning\, and validation. \nJoin us this May to maximize your facility flexibility\, asset lifespan\, productivity & compliance through excellent engineering\, robust validation & technology adoption! \nTo know more visit: https://ter.li/qe5ezy
URL:https://www.pharmajournalist.com/event/3rd-manufacturing-engineering-facility-management-in-pharma-summit/
LOCATION:Boston Park Plaza\, 50 Park Plaza\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR